Cited by 15Bone Metabolism and DiseasesBone Tissue Engineering MaterialsMesenchymal stem cell research

Effects of the combination of dexamethasone and fibroblast growth factor-2 on differentiation of osteoprecursor cells

Open access
PARK, JUN-BEOM·2014·Molecular Medicine Reports

Abstract

Dexamethasone is a potent modulator of osteogenic differentiation and previous studies have shown that dexamethasone increases the bone formation capacity of osteoprogenitor cells in vitro. Fibroblast growth factor‑2 (FGF‑2) is reported to have numerous biological activities, including stimulation of cell growth, migration, angiogenesis, wound healing, tissue repair, differentiation and morphogenesis. In the present study, the dose‑dependent effect of dexamethasone and FGF‑2 on the differentiation of osteoprecursor cells was evaluated. The alkaline phosphatase (ALP) activity test was performed to assess differentiation and protein expression associated with bone formation was measured by western blot analysis. The results showed that the protein content of the cultures grown with the osteogenic differentiation media in the presence of 2 ng/ml FGF‑2 was increased compared with that of the untreated control. ALP activity was increased when cells were treated with dexamethasone, with the highest value at 100 nM. The addition of 20 ng/ml FGF‑2 to 100 nM dexamethasone showed an increase in ALP activity, however, this was not statistically significant. The combination of 100 nM dexamethasone and 20 ng/ml FGF‑2 produced the highest expression of bone morphogenetic protein receptor‑IA and bone morphogenetic protein receptor‑II, leading to the highest value of pSmad1/5/8 expression. Within the limits of this study, dexamethasone significantly enhanced osteoblast differentiation, however, the combined delivery of dexamethasone and FGF‑2 did not produce synergistic effects on osteoblast differentiation under the current experimental conditions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/mmr.2013.1811

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
PARK, J.-B.
Affiliations
The Catholic University of Korea Seoul St. Mary's Hospital (KR)
Corresponding author
PARK, JUN-BEOM
Venue
Molecular Medicine Reports
Published
2013-11-19
Volume
9
Issue
2
Pages
659-662
ISSN
  • 1791-2997 (ISSN-L)
  • 1791-3004
OpenAlex
W2063062118
Cited by
15
References
19
Citations by year
2026: 1 · 2025: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2018: 3 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 1
FWCI
0.60
Type
journal article
Language
en
Open access
Locations
  • Molecular Medicine Reports (publishedVersion)
  • PubMed (publishedVersion)
Funders
Catholic University of Korea
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
dexamethasone, fibroblast growth factor 2, osteogenic differentiation, osteoprogenitor cells, alkaline phosphatase activity, Smad1/5/8 phosphorylation, synergistic effect, glucocorticoids, bone formation
MeSH terms
Alkaline Phosphatase, Animals, Cell Differentiation, Cells, Cultured, Dexamethasone, Drug Combinations, Humans, Osteogenesis, Transforming Growth Factor beta, Fibroblast Growth Factor 2, Gene Expression Regulation, Developmental, Bone Morphogenetic Proteins, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review